Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
01 1SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN
02 1EUROAPI FRANCE Vertolaye FR
03 1HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang CN
04 1PFIZER INC. New York US
05 1Pharmacia & Upjohn Company Kalamazoo US
06 2TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin CN
07 1ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Xianju CN
01 5Methylprednisolone
02 2Methylprednisolone, Micronised
03 1Methylprednisolone, TY II
01 4China
02 1France
03 1India
04 2U.S.A
01 1Expired
02 6Valid
03 1Withdrawn by Holder
Methylprednisolone, Micronised
Certificate Number : R1-CEP 2014-015 - Rev 01
Status : Valid
Issue Date : 2022-05-03
Type : Chemical
Substance Number : 561
Methylprednisolone, Micronised
Certificate Number : R1-CEP 1996-018 - Rev 09
Status : Valid
Issue Date : 2021-12-16
Type : Chemical
Substance Number : 561
Certificate Number : CEP 2021-208 - Rev 00
Status : Valid
Issue Date : 2024-02-12
Type : Chemical
Substance Number : 561
Certificate Number : CEP 2006-058 - Rev 03
Status : Valid
Issue Date : 2024-03-07
Type : Chemical
Substance Number : 561
Certificate Number : R0-CEP 2000-361 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2001-10-24
Type : TSE
Substance Number : 561
Certificate Number : R1-CEP 2012-307 - Rev 01
Status : Valid
Issue Date : 2022-10-04
Type : Chemical
Substance Number : 561
Certificate Number : R0-CEP 2006-265 - Rev 02
Status : Expired
Issue Date : 2011-12-02
Type : Chemical
Substance Number : 561
Certificate Number : R1-CEP 2011-027 - Rev 01
Status : Valid
Issue Date : 2021-03-22
Type : Chemical
Substance Number : 561
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one, including repackagers and relabelers. The FDA regulates (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one supplier is an individual or a company that provides (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one active pharmaceutical ingredient (API) or (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one finished formulations upon request. The (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers may include (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one API manufacturers, exporters, distributors and traders.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEP of the European Pharmacopoeia monograph is often referred to as a (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one Certificate of Suitability (COS). The purpose of a (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one to their clients by showing that a (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEP has been issued for it. The manufacturer submits a (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEP (COS) as part of the market authorization procedure, and it takes on the role of a (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEP holder for the record. Additionally, the data presented in the (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one DMF.
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers with CEP (COS) on PharmaCompass.
We have 6 companies offering (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?